Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474889 · ClinicalTrials.gov registry record · NA
Glucose Counterregulation in Long Standing Type 1 Diabetes
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01474889: Completed NA study, sponsored by University of Pennsylvania.
NCT01474889 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01474889, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Enrollment for this study is complete. This study is designed to determine if use of a real-time continuous glucose monitor (RT-CGM) can reverse defective Glucose counter regulation and hypoglycemia unawareness in long standing type 1 diabetes.
Interventions
- DEVICE RT-CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-10 |
| Est. Completion | 2021-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474889
The ClinicalTrials.gov registry entry for NCT01474889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RT-CGM is the first listed.
NCT01474889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474889 about?
NCT01474889 is a clinical study titled "Glucose Counterregulation in Long Standing Type 1 Diabetes". Enrollment for this study is complete. This study is designed to determine if use of a real-time continuous glucose monitor (RT-CGM) can reverse defective Glucose counter regulation and hypoglycemia unawareness in long standing type 1 diabetes.
What is the current status of trial NCT01474889?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2011-10. Estimated completion is 2021-03-05.
What interventions are being tested in trial NCT01474889?
The interventions under investigation include: RT-CGM (DEVICE).
Who is sponsoring clinical trial NCT01474889?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.